AAAAAA

   
Results: 1-9 |
Results: 9
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families
Authors: Vasen, HFA Stormorken, A Menko, FH Nagengast, FM Kleibeuker, JH Griffioen, G Taal, BG Moller, P Wijnen, JT
Citation: Hfa. Vasen et al., MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families, J CL ONCOL, 19(20), 2001, pp. 4074-4080
Survival analysis in familial ovarian cancer, a case control study
Authors: Zweemer, RP Verheijen, RHM Coebergh, JWW Jacobs, IJ van Diest, PJ Gille, JJP Skates, S Menko, FH Ten Kate, LP Kenemans, P
Citation: Rp. Zweemer et al., Survival analysis in familial ovarian cancer, a case control study, EUR J OB GY, 98(2), 2001, pp. 219-223
Comparative genomic hybridization of microdissected familial ovarian carcinoma: Two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma
Authors: Zweemer, RP Ryan, A Snijders, AM Hermsen, MAJA Meijer, GA Beller, U Menko, FH Jacobs, IJ Baak, JPA Verheijen, RHM Kenemans, P van Diest, PJ
Citation: Rp. Zweemer et al., Comparative genomic hybridization of microdissected familial ovarian carcinoma: Two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma, LAB INV, 81(10), 2001, pp. 1363-1370
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
Authors: Piek, JMJ van Diest, PJ Zweemer, RP Jansen, JW Poort-Keesom, RJJ Menko, FH Gille, JJP Jongsma, APM Pals, G Kenemans, P Verheijen, RHM
Citation: Jmj. Piek et al., Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer, J PATHOLOGY, 195(4), 2001, pp. 451-456
Molecular evidence linking primary cancer of the Fallopian tube to BRCA1 germline mutations
Authors: Zweemer, RP van Diest, PJ Verheijen, RHM Ryan, A Gille, JJP Sijmons, RH Jacobs, IJ Menko, FH Kenemans, P
Citation: Rp. Zweemer et al., Molecular evidence linking primary cancer of the Fallopian tube to BRCA1 germline mutations, GYNECOL ONC, 76(1), 2000, pp. 45-50
Differences between hereditary and sporadic ovarian cancer
Authors: Zweemer, RP Verheijen, RHM Menko, FH Gille, JJP van Diest, PJ Coebergh, JW Shaw, PA Jacobs, IJ Kenemans, P
Citation: Rp. Zweemer et al., Differences between hereditary and sporadic ovarian cancer, EUR J OB GY, 82(2), 1999, pp. 151-153
Familial breast cancer: Clinical services in the Netherlands
Authors: Menko, FH
Citation: Fh. Menko, Familial breast cancer: Clinical services in the Netherlands, DIS MARKER, 15(1-3), 1999, pp. 31-33
Accumulation of p53 protein is frequent in ovarian cancers associated withBRCA1 and BRCA2 germline mutations
Authors: Zweemer, RP Shaw, PA Verheijen, RMH Ryan, A Berchuck, A Ponder, BAJ Risch, H McLaughlin, JR Narod, SA Menko, FH Kenemans, P Jacobs, IJ
Citation: Rp. Zweemer et al., Accumulation of p53 protein is frequent in ovarian cancers associated withBRCA1 and BRCA2 germline mutations, J CLIN PATH, 52(5), 1999, pp. 372-375
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
Authors: Ligtenberg, MJL Hogervorst, FBL Willems, HW Arts, PJW Brink, G Hageman, S Bosgoed, EAJ Van der Looij, E Rookus, MA Devilee, P Vos, EMAW Wigbout, G Struycken, PM Menko, FH Rutgers, EJT Hoefsloot, EH Mariman, ECM Brunner, HG Van't Veer, LJ
Citation: Mjl. Ligtenberg et al., Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2, BR J CANC, 79(9-10), 1999, pp. 1475-1478
Risultati: 1-9 |